Post Marketing Surveillance

Post marketing surveillance is an important component of the science of pharmacovigilance, which entails monitoring the safety of pharmaceutical goods and medical devices after they are introduced to the market. Because clinical trials—involving relatively few individuals who typically do not have additional medical conditions that exist in the general population—are the foundation for the acceptance and approval of drugs and medical devices, post-marketing surveillance can further hone, or confirm, the safety of a drug or device after it has been used in the general population by numerous individuals with a variety of medical conditions.

    Related Conference of Post Marketing Surveillance

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Post Marketing Surveillance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in